Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flunisolide HFA Dosing in Children with Asthma and Small Airway Disease
NCT02404103Completed
- Sponsor
- University of Louisville
- Start
- Mar 2015
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of flunisolide in asthma (2 arms), sponsored by University of Louisville. Primary endpoints: Forced Expiratory Volume in 1 second at 6 weeks, Forced Expiratory Flow 25-75% at 6 weeks and 4 more. Started Mar 2015; status: completed.
02
Drugs
flunisolide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02404103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404103.